Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.66 |
| ▸ | HTR2A | P28223 | 5/20 | 0.61 |
| ▸ | HTR1A | P08908 | 4/20 | 0.61 |
| ▸ | HTR6 | P50406 | 2/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | HTR2C | P28335 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.61 |
| ▸ | MPO | P05164 | 1/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | HTR1D | P28221 | 1/20 | 0.61 |
| ▸ | HTR1B | P28222 | 1/20 | 0.61 |
| ▸ | HTR7 | P34969 | 1/20 | 0.61 |
| ▸ | CTSK | P43235 | 1/20 | 0.61 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.61 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.61 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20648101 | 0.98 | SLC6A4 (0.64) | SLC6A4HTR2AHTR1AHTR6ALOX12 | |
| SCHEMBL1563873 | 0.98 | SLC6A4 (0.64) | SLC6A4HTR2AHTR1AHTR6ALOX12 | |
| SCHEMBL22582285 | 0.98 | SLC6A4 (0.64) | SLC6A4HTR2AHTR1AHTR6ALOX12 | |
| SCHEMBL24961938 | 0.98 | SLC6A4 (0.64) | SLC6A4HTR2AHTR1AHTR6ALOX12 | |
| SCHEMBL8079335 | 0.98 | SLC6A4 (0.64) | SLC6A4HTR2AHTR1AHTR6ALOX12 | |
| SCHEMBL25140788 | 0.98 | SLC6A4 (0.64) | SLC6A4HTR2AHTR1AHTR6ALOX12 | |
| SCHEMBL13856893 | 0.98 | SLC6A4 (0.64) | SLC6A4HTR2AHTR1AHTR6ALOX12 | |
| SCHEMBL266641 | 0.95 | SLC6A4 (0.68) | SLC6A4HTR2AHTR1AHTR6CYP3A4 | |
| Ammonia Solution, Strong SCHEMBL10491416 | 0.93 | SLC6A4 (0.66) | SLC6A4HTR2AHTR1AHTR6CYP3A4 | |
| SCHEMBL7004146 | 0.91 | HTR2A (0.71) | SLC6A4HTR2AHTR1AHTR6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | claimed |
| CN-116082216-A | 3-aryl indole KDM1A/HDACs double-target inhibitor, and preparation method and application thereof | 阜外华中心血管病医院 | 2023-05-09 | — | — | CN | claimed |
| CN-109438318-B | Synthesis method of 3-aryl indole and derivatives thereof | 湖南医药学院 | 2022-05-03 | — | — | CN | claimed |
| CN-110498757-B | Synthesis method of metal-free 3-acyl indole compound | 中国科学院兰州化学物理研究所 | 2022-03-15 | — | — | CN | claimed |
| CN-110627705-A | N-benzyl indole thiosemicarbazone derivative, preparation and application | 西北农林科技大学 | 2019-12-31 | — | — | CN | claimed |
| US-20110065715-A1 | Nogo Receptor Binding Small Molecules to Promote Axonal Growth | YALE UNIVERSITY (US) | 2011-03-17 | — | — | US | claimed |
| EP-2220499-A2 | NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH | Yale University (US) | 2010-08-25 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| WO-2009073141-A2 | NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH | STRITTMATTER STEPHEN M (US) | 2009-06-11 | — | — | WO | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| EP-1509250-B1 | METHODS COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR MODULATING BONE GROWTH | YISSUM RES DEV CO (IL) | 2008-05-07 | — | — | EP | claimed |
| US-6515141-B1 | Process for the preparation of indole derivatives or salts thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-02-04 | — | — | US | claimed |
| EP-1207153-A1 | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES OR SALTS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-22 | — | — | EP | claimed |
| US-5393761-A | Treatment of nervous system disorders | H. LUNDBECK A/S (DK) | 1995-02-28 | — | — | US | claimed |
| EP-0470039-B1 | Novel 3-arylindole and 3-arylindazole derivatives | LUNDBECK & CO AS H (DK) | 1994-12-07 | — | — | EP | claimed |
| EP-0621781-A1 | USE OF 3-ARYLINDOLE AND 3-ARYLINDAZOLE DERIVATIVES FOR THE TREATMENT OF PSYCHOSES | H. LUNDBECK A/S (DK) | 1994-11-02 | — | — | EP | claimed |
| WO-1993014758-A1 | USE OF 3-ARYLINDOLE AND 3-ARYLINDAZOLE DERIVATIVES FOR THE TREATMENT OF PSYCHOSES | H. LUNDBECK A/S (DK) | 1993-08-05 | — | — | WO | claimed |
| EP-0470039-A2 | Novel 3-arylindole and 3-arylindazole derivatives | H. LUNDBECK A/S (DK) | 1992-02-05 | — | — | EP | claimed |
| JP-63166877-A | — | — | None | — | — | JP | disclosed |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
| CN-117342996-A | Preparation and application of trans-2, 3-diacyl indoline compounds | 郑州大学 | 2024-01-05 | — | — | CN | disclosed |
| EP-4276534-A1 | MASK BLANK, RESIST PATTERN FORMING PROCESS AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION | Shin-Etsu Chemical Co., Ltd. (JP) | 2023-11-15 | — | — | EP | disclosed |
| CN-116903514-A | Preparation method of 3-aryl indole-2-ketone compound | 西北大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-116082217-B | N-axis chiral bisindole compound and synthesis method thereof | 江苏师范大学 | 2023-07-14 | — | — | CN | disclosed |
| WO-2023129976-A1 | SALT AND SOLID FORMS OF KETANSERIN | TERRAN BIOSCIENCES, INC. (US) | 2023-07-06 | — | — | WO | disclosed |
| CN-116082216-A | 3-aryl indole KDM1A/HDACs double-target inhibitor, and preparation method and application thereof | 阜外华中心血管病医院 | 2023-05-09 | — | — | CN | disclosed |
| CN-116082217-A | N-axis chiral bisindole compound and synthesis method thereof | 江苏师范大学 | 2023-05-09 | — | — | CN | disclosed |
| CN-115677674-A | Preparation method of heterocyclic compound containing indolone and 3-acyl benzofuran or indole structure | 浙江理工大学 | 2023-02-03 | — | — | CN | disclosed |
| CN-113336689-B | Synthesis method and anticancer activity of 3- (alpha-fluorovinyl/carbonyl) indole compound | 河南师范大学 | 2022-06-17 | — | — | CN | disclosed |
| CN-114436943-A | Method for synthesizing spiro indole compound through double oxidative dehydroaromatization | 河南师范大学 | 2022-05-06 | — | — | CN | disclosed |
| CN-109438318-B | Synthesis method of 3-aryl indole and derivatives thereof | 湖南医药学院 | 2022-05-03 | — | — | CN | disclosed |
| CN-109438318-B | Synthesis method of 3-aryl indole and derivatives thereof | 湖南医药学院 | 2022-05-03 | — | — | CN | disclosed |
| CN-109438318-B | Synthesis method of 3-aryl indole and derivatives thereof | 湖南医药学院 | 2022-05-03 | — | — | CN | disclosed |
| CN-114394891-A | Compound prepared by catalyzing chalcone with monovalent iodine reagent, and preparation method and application thereof | 化学与精细化工广东省实验室 | 2022-04-26 | — | — | CN | disclosed |
| CN-110498757-B | Synthesis method of metal-free 3-acyl indole compound | 中国科学院兰州化学物理研究所 | 2022-03-15 | — | — | CN | disclosed |
| CN-110498757-B | Synthesis method of metal-free 3-acyl indole compound | 中国科学院兰州化学物理研究所 | 2022-03-15 | — | — | CN | disclosed |
| CN-110498757-B | Synthesis method of metal-free 3-acyl indole compound | 中国科学院兰州化学物理研究所 | 2022-03-15 | — | — | CN | disclosed |
| WO-2021250059-A1 | METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2021-12-16 | — | — | WO | disclosed |
| CN-113336689-A | Synthesis method and anticancer activity of 3- (alpha-fluorovinyl/carbonyl) indole compound | 河南师范大学 | 2021-09-03 | — | — | CN | disclosed |
| CN-109232361-B | Synthesis method of C3-carbonyl acetyl indole derivative | 华南理工大学 | 2021-08-10 | — | — | CN | disclosed |
| CN-110627705-B | N-benzyl indole thiosemicarbazone derivative, preparation and application | 西北农林科技大学 | 2021-07-16 | — | — | CN | disclosed |
| CN-108624633-B | Preparation method and application of indole-3-formaldehyde | 中国热带农业科学院海口实验站 | 2021-05-18 | — | — | CN | disclosed |
| CN-108752256-B | Preparation method of N-acyl indole compound based on carboxylic acid alkenyl ester as acylation reagent | 六盘水师范学院 | 2021-04-13 | — | — | CN | disclosed |
| WO-2020205934-A1 | PYRROLE COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2020-10-08 | — | — | WO | disclosed |
| US-10752585-B2 | Process for the preparation of Zafirlukast and analogs thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-08-25 | — | — | US | disclosed |
| US-20200223826-A1 | Glucose-6-Phosphate Dehydrogenase (G6PD)-Modulating Agents And Methods Of Treating G6PD Deficiency | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2020-07-16 | — | — | US | disclosed |
| US-20200216390-A1 | PROCESS FOR THE PREPARATION OF ZAFIRLUKAST AND ANALOGS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-07-09 | — | — | US | disclosed |
| CN-110627705-A | N-benzyl indole thiosemicarbazone derivative, preparation and application | 西北农林科技大学 | 2019-12-31 | — | — | CN | disclosed |
| EP-3519567-A1 | ENGINEERED MICROORGANISMS FOR PRODUCTION OF COMMODITY CHEMICALS AND CELLULAR BIOMASS | The Regents of The University of California (US) | 2019-08-07 | — | — | EP | disclosed |
| CN-110054579-A | A kind of preparation method and applications of 4- (1-H indoles) phenol derivatives | 贵州省中国科学院天然产物化学重点实验室 | 2019-07-26 | — | — | CN | disclosed |
| US-10266526-B2 | Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer | Epizyme, Inc. (US) | 2019-04-23 | — | — | US | disclosed |
| CN-109232361-A | A kind of synthetic method of C3- carbonyl acetyl indole derivative | 华南理工大学 | 2019-01-18 | — | — | CN | disclosed |
| US-20180312493-A1 | Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses Therefor | CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) | 2018-11-01 | — | — | US | disclosed |
| WO-2018151833-A1 | HIGH PRESSURE ZONE FORMATION FOR PRETREATMENT | SWEETWATER ENERGY, INC. (US) | 2018-08-23 | — | — | WO | disclosed |
| WO-2018067458-A1 | ENGINEERED MICROORGANISMS FOR PRODUCTION OF COMMODITY CHEMICALS AND CELLULAR BIOMASS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-04-12 | — | — | WO | disclosed |
| WO-2018018863-A1 | MILD AND EFFICIENT PREPARATION METHOD FOR Α-ACYLOXY ALKENYL AMIDE COMPOUND AND USE THEREOF IN SYNTHESIS OF AMIDE AND POLYPEPTIDE | 江西师范大学 | 2018-02-01 | — | — | WO | disclosed |
| US-20170355695-A1 | SMYD Inhibitors | Epizyme, Inc. (US) | 2017-12-14 | — | — | US | disclosed |
| WO-2017200970-A1 | POTENT AND SELECTIVE MU OPIOID RECEPTOR MODULATORS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2017-11-23 | — | — | WO | disclosed |
| US-20170325457-A1 | FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS | Preceres Inc. (US) | 2017-11-16 | — | — | US | disclosed |
| EP-3230463-A1 | RAPID PRETREATMENT | Sweetwater Energy, Inc. (US) | 2017-10-18 | — | — | EP | disclosed |
| WO-2017075694-A1 | ANTIBIOTIC COMPOUNDS, PHARMACEUTICAL FORMULATIONS THEREOF AND METHODS AND USES THEREFOR | SIMON FRASER UNIVERSITY (CA) | 2017-05-11 | — | — | WO | disclosed |
| WO-2016094594-A1 | RAPID PRETREATMENT | SWEETWATER ENERGY, INC. (US) | 2016-06-16 | — | — | WO | disclosed |
| EP-1294699-B1 | MODULATORS OF TNF- ALPHA SIGNALLING | GENZYME CORP (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2015179243-A1 | SUGAR SEPARATION AND PURIFICATION THROUGH FILTRATION | SWEETWATER ENERGY, INC. (US) | 2015-11-26 | — | — | WO | disclosed |
| EP-2836602-A1 | METHODS AND SYSTEMS FOR SACCHARIFICATION OF BIOMASS | Sweetwater Energy, Inc. (US) | 2015-02-18 | — | — | EP | disclosed |
| WO-2014190294-A1 | SUGAR SEPARATION AND PURIFICATION FROM BIOMASS | SWEETWATER ENERGY, INC. (US) | 2014-11-27 | — | — | WO | disclosed |
| WO-2014169079-A2 | INCREASED PRODUCTIVITY DURING FERMENTATION | SWEETWATER ENERGY, INC. (US) | 2014-10-16 | — | — | WO | disclosed |
| WO-2014143753-A1 | CARBON PURIFICATION OF CONCENTRATED SUGAR STREAMS DERIVED FROM PRETREATED BIOMASS | SWEETWATER ENERGY, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014026154-A1 | OPTIMIZED PRETREATMENT OF BIOMASS | SWEETWATER ENERGY, INC. (US) | 2014-02-13 | — | — | WO | disclosed |
| WO-2013155496-A1 | METHODS AND SYSTEMS FOR SACCHARIFICATION OF BIOMASS | SWEETWATER ENERGY, INC. (US) | 2013-10-17 | — | — | WO | disclosed |
| WO-2013148415-A1 | ENHANCED FERMENTATION FROM PRETREATMENT PRODUCTS | SWEETWATER ENERGY, INC. (US) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013115959-A1 | METHODS AND COMPOSITIONS FOR GROWTH OF YEAST ON ALGINATE | BIO ARCHITECTURE LAB, INC. (US) | 2013-08-08 | — | — | WO | disclosed |
| WO-2013085555-A2 | MODULATION OF FERMENTATION PRODUCTS THROUGH VITAMIN SUPPLEMENTATION | QTEROS, INC. (US) | 2013-06-13 | — | — | WO | disclosed |
| US-20120270827-A1 | Indole Antiviral Compositions And Methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-10-25 | — | — | US | disclosed |
| WO-2012103385-A2 | BIOCATALYSTS SYNTHESIZING DEREGULATED CELLULASES | QTEROS, INC. (US) | 2012-08-02 | — | — | WO | disclosed |
| CN-102127002-B | Method for preparing 3,3-diaryl substituted and 3-alkyl-3-aryl substituted oxoindole derivative | UNIV EAST CHINA NORMAL | 2012-06-27 | — | — | CN | disclosed |
| WO-2012083244-A2 | BIOFUEL PRODUCTION USING BIOFILM IN FERMENTATION | QTEROS, INC. (US) | 2012-06-21 | — | — | WO | disclosed |
| US-8202844-B2 | Indole antiviral compositions and methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-06-19 | — | — | US | disclosed |
| WO-2012068537-A2 | NEW BIOCATALYSTS AND PRIMERS FOR PRODUCTION OF CHEMICALS | QTEROS, INC. (US) | 2012-05-24 | — | — | WO | disclosed |
| EP-2424982-A1 | ADAPTING MICROORGANISMS FOR AGRICULTURAL PRODUCTS | De Crecy, Eudes (US) | 2012-03-07 | — | — | EP | disclosed |
| EP-2421984-A1 | COMPOSITIONS AND METHODS FOR FERMENTATION OF BIOMASS | Qteros, Inc. (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1951225-B1 | 3-ACYLINDOLE DERIVATIVES THE PREPARATION AND THE THERAPEUTIC USE THEREOF | SANOFI SA (FR) | 2012-02-01 | — | — | EP | disclosed |
| EP-2406381-A1 | PRODUCTION OF FERMENTIVE END PRODUCTS FROM CLOSTRIDIUM SP. | Qteros, Inc. (US) | 2012-01-18 | — | — | EP | disclosed |
| WO-2011149956-A2 | METHODS FOR PRODUCING CHEMICAL PRODUCTS FROM FERMENTATION BYPRODUCTS | QTEROS, INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011137401-A2 | REDIRECTED BIOENERGETICS IN RECOMBINANT CELLULOLYTIC CLOSTRIDIUM MICROORGANISMS | QTEROS, INC. (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011133984-A2 | NEW BACTERIUM FOR PRODUCTION OF CHEMICALS AND RECOMBINANTS THEREOF | QTEROS, INC. (US) | 2011-10-27 | — | — | WO | disclosed |
| WO-2011133952-A2 | NEW BACTERIUM FOR PRODUCTION OF CHEMICALS AND RECOMBINANTS THEREOF | QTEROS, INC. (US) | 2011-10-27 | — | — | WO | disclosed |
| WO-2011116358-A2 | MICROORGANISMS WITH INACTIVATED LACTATE DEHYDROGENASE GENE (LDH) FOR CHEMICAL PRODUCTION | QTEROS INC. (US) | 2011-09-22 | — | — | WO | disclosed |
| US-20110178038-A1 | Indole Antiviral Compositions And Methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-07-21 | — | — | US | disclosed |
| WO-2010123932-A9 | COMPOSITIONS AND METHODS FOR FERMENTATION OF BIOMASS | QTEROS, INC. (US) | 2011-06-09 | — | — | WO | disclosed |
| US-7928080-B2 | Indole antiviral compositions and methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-04-19 | — | — | US | disclosed |
| WO-2010104896-A9 | PRODUCTION OF FERMENTIVE END PRODUCTS FROM CLOSTRIDIUM SP. | QTEROS, INC. (US) | 2011-04-14 | — | — | WO | disclosed |
| US-20110065715-A1 | Nogo Receptor Binding Small Molecules to Promote Axonal Growth | YALE UNIVERSITY (US) | 2011-03-17 | — | — | US | disclosed |
| WO-2011008564-A2 | COMPOSITIONS AND METHODS FOR IMPROVED SACCHARIFICATION OF BIOMASS | QTEROS, INC. (US) | 2011-01-20 | — | — | WO | disclosed |
| WO-2011002824-A1 | PRETREATMENT OF BIOMASS | QTEROS, INC. (US) | 2011-01-06 | — | — | WO | disclosed |
| WO-2010127182-A1 | ADAPTING MICROORGANISMS FOR AGRICULTURAL PRODUCTS | EVOLUGATE, LLC (US) | 2010-11-04 | — | — | WO | disclosed |
| WO-2010124147-A1 | COMPOSITIONS AND METHODS FOR METHANE PRODUCTION | QTEROS, INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010123932-A1 | COMPOSITIONS AND METHODS FOR FERMENTATION OF BIOMASS | QTEROS, INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010104896-A1 | PRODUCTION OF FERMENTIVE END PRODUCTS FROM CLOSTRIDIUM SP. | QTEROS, INC. (US) | 2010-09-16 | — | — | WO | disclosed |
| EP-2220499-A2 | NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH | Yale University (US) | 2010-08-25 | — | — | EP | disclosed |
| US-7741363-B2 | 3-Acylindole derivatives, preparation and therapeutic use thereof | SANOFI-AVENTIS (FR) | 2010-06-22 | — | — | US | disclosed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | disclosed |
| US-20090318446-A1 | 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy | CYCLACEL LIMITED (GB) | 2009-12-24 | — | — | US | disclosed |
| US-7625871-B2 | Indole antiviral compositions and methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-12-01 | — | — | US | disclosed |
| US-20090281052-A1 | Indole Antiviral Compositions And Methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-11-12 | — | — | US | disclosed |
| WO-2009073141-A2 | NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH | STRITTMATTER STEPHEN M (US) | 2009-06-11 | — | — | WO | disclosed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| US-20080275102-A1 | 3-ACYLINDOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2008-11-06 | — | — | US | disclosed |
| US-7419963-B2 | Indole antiviral compositions and methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-09-02 | — | — | US | disclosed |
| EP-1951225-A2 | 3-ACYLINDOLE DERIVATIVES THE PREPARATION AND THE THERAPEUTIC USE THEREOF | sanofi-aventis (FR) | 2008-08-06 | — | — | EP | disclosed |
| US-20080146517-A1 | Indole Antiviral Compositions And Methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2008-06-19 | — | — | US | disclosed |
| US-20080090871-A1 | CANNABIMIMETIC INDOLE DERIVATIVES | MAKRIYANNIS ALEXANDROS | 2008-04-17 | — | — | US | disclosed |
| CN-100351234-C | Bis-heterocyclic compounds with antitumour and chemosensitising activity | SIGMA TAU IND FARMACEUTI (IT) | 2007-11-28 | — | — | CN | disclosed |
| EP-1836194-A1 | 4- (1H-INDOL-3-YL) -PYRIMIDIN-2-YLAMINE DERIVATES AND THEIR USE IN THERAPY | Cyclacel Limited (GB) | 2007-09-26 | — | — | EP | disclosed |
| US-7241799-B2 | Cannabimimetic indole derivatives | UNIVERSITY OF CONNECTICUT (US) | 2007-07-10 | — | — | US | disclosed |
| WO-2007057571-A2 | 3-ACYLINDOLE DERIVATIVES THE PREPARATION AND THE THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-05-24 | — | — | WO | disclosed |
| US-20070082872-A1 | Indole-containing compounds with anti-tubulin and vascular targeting activity | BAYLOR UNIVERSITY | 2007-04-12 | — | — | US | disclosed |
| EP-1702617-A1 | Cannabimimetic indole derivatives | THE UNIVERSITY OF CONNECTICUT (US) | 2006-09-20 | — | — | EP | disclosed |
| EP-1223929-B1 | CANNABIMIMETIC INDOLE DERIVATIVES | UNIV CONNECTICUT (US) | 2006-08-23 | — | — | EP | disclosed |
| US-20060172019-A1 | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders | ABERDEEN, THE UNIVERSITY COURT OF THE UNIVERSITY OF (GB) | 2006-08-03 | — | — | US | disclosed |
| WO-2006075152-A1 | 4- (1H-INDOL-3-YL) -PYRIMIDIN-2-YLAMINE DERIVATES AND THEIR USE IN THERAPY | CYCLACEL LIMITED (GB) | 2006-07-20 | — | — | WO | disclosed |
| EP-1677784-A1 | INDOLE ANTIVIRAL COMPOSITIONS AND METHODS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2006-07-12 | — | — | EP | disclosed |
| CN-1247589-C | Tricyclic derivatives of indole with antiangiogenic activity | SIGMA TAU IND FARMACEUTI (IT) | 2006-03-29 | — | — | CN | disclosed |
| CN-1733722-A | Bis-heterocyclic compounds with antitumour and chemosensitising activity | SIGMA TAU IND FARMACEUTI (IT) | 2006-02-15 | — | — | CN | disclosed |
| US-6995184-B2 | Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors | SANOFI-AVENTIS (FR) | 2006-02-07 | — | — | US | disclosed |
| CN-1234688-C | 3-aroyl indoles and their use as CB2Use of receptor agonists | SANOFI ANVANT (FR) | 2006-01-04 | — | — | CN | disclosed |
| EP-1606019-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | The University Court of The University of Aberdeen (GB) | 2005-12-21 | — | — | EP | disclosed |
| CN-1232518-C | Bis-heterocyclic compounds with antitumor and chemosensitive activity | SIGMA TAU IND FARMACEUTI (IT) | 2005-12-21 | — | — | CN | disclosed |
| US-20050143329-A1 | Indole antiviral compositions and methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2005-06-30 | — | — | US | disclosed |
| US-20050124620-A1 | Indole derivatives having an acidic moiety that inhibit or modulate activity of p38 map kinase mediating a disease state; e.g., 3-(2-(4-pyridyl)ethyl)-5-(3-trifluoromethoxybenzamido)indole; enzyme inhibitors; antiarthritic, -inflammatory, and -carcinogenic agents; respiratory disorders; AIDS; Alzheimer's | FREDERICKSON MARTYN (GB) | 2005-06-09 | — | — | US | disclosed |
| US-20050119234-A1 | Cannabimimetic indole derivatives | UNIVERSITY OF CONNECTICUT (US) | 2005-06-02 | — | — | US | disclosed |
| US-6900236-B1 | Cannabimimetic indole derivatives | UNIVERSITY OF CONNECTICUT (US) | 2005-05-31 | — | — | US | disclosed |
| WO-2005034943-A1 | INDOLE ANTIVIRAL COMPOSITIONS AND METHODS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2005-04-21 | — | — | WO | disclosed |
| US-6858739-B2 | Indole and benzimidazole 15-lipoxygenase inhibitors | WARNER-LAMBERT COMPANY (US) | 2005-02-22 | — | — | US | disclosed |
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CLEMSON UNIVERSITY | 2005-01-13 | — | — | US | disclosed |
| EP-1495016-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS MODULATORS OF P38 MAP KINASE | Astex Technology Limited (GB) | 2005-01-12 | — | — | EP | disclosed |
| EP-0976732-B1 | 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES | EISAI CO LTD (JP) | 2004-11-24 | — | — | EP | disclosed |
| WO-2004099139-A1 | INDOLE-CONTAINING COMPOUNDS WITH ANTI-TUBULIN AND VASCULAR TARGETING ACTIVITY | BAYLOR UNIVERSITY (US) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004078261-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2004-09-16 | — | — | WO | disclosed |
| CN-1483023-A | 3-arylindole derivatives and their use as cb2 receptor agonists | ʥŵ��-�ϳ�ʵ���ҹ�˾ | 2004-03-17 | — | — | CN | disclosed |
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | CONNOR DAVID THOMAS (US) | 2004-02-26 | — | — | US | disclosed |
| CN-1473150-A | Bis-heterocyclic compounds with antitumor and chemosensitive activity | ϣ��������ҩ��ҵ��˾ | 2004-02-04 | — | — | CN | disclosed |
| CN-1471535-A | Tricyclic derivatives of indole with antiangiogenic activity | ϣ��������ҩ��ҵ��˾ | 2004-01-28 | — | — | CN | disclosed |
| WO-2003087087-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS MODULATORS OF P38 MAP KINASE | ASTEX TECHNOLOGY LIMITED (GB) | 2003-10-23 | — | — | WO | disclosed |
| EP-0772592-B1 | 1H-INDOLE-1-FUNCTIONAL sPLA 2 INHIBITORS | LILLY CO ELI (US) | 2003-05-02 | — | — | EP | disclosed |
| EP-1294686-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2003-03-26 | — | — | EP | disclosed |
| EP-1088817-B1 | Process for the preparation of 3-acyl-indoles | PFIZER LTD (GB) | 2003-02-26 | — | — | EP | disclosed |
| US-6515141-B1 | Process for the preparation of indole derivatives or salts thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-02-04 | — | — | US | disclosed |
| US-6515141-B1 | Process for the preparation of indole derivatives or salts thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-02-04 | — | — | US | disclosed |
| CN-1382123-A | Process for preparation of indole derivatives or salts thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-11-27 | — | — | CN | disclosed |
| EP-1207153-A1 | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES OR SALTS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| EP-1207153-A1 | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES OR SALTS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| WO-2001096299-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| EP-0821685-B1 | INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LAB (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-1088817-A3 | Process for the preparation of 3-acyl-indoles | Pfizer Limited (GB) | 2001-08-29 | — | — | EP | disclosed |
| EP-0823903-B1 | HETEROCYCLIC DIARYL COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME, AND USES THEREOF | CT INTERNAT DE RECH S (FR) | 2001-07-18 | — | — | EP | disclosed |
| EP-1088817-A2 | Process for the preparation of 3-acyl-indoles | Pfizer Limited (GB) | 2001-04-04 | — | — | EP | disclosed |
| WO-2001016101-A1 | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES OR SALTS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-08 | — | — | WO | disclosed |
| US-5936098-A | Process for producing indoline compounds and intermediates for the production of the same | TOKYO TANABE COMPANY LIMITED (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0595924-B1 | PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LAB (US) | 1999-04-14 | — | — | EP | disclosed |
| EP-0772592-A4 | 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS | LILLY CO ELI (US) | 1998-07-08 | — | — | EP | disclosed |
| EP-0810214-A4 | PROCESS FOR PRODUCING INDOLINE COMPOUNDS AND INTERMEDIATES FOR THE PRODUCTION OF THE SAME | TOKYO TANABE CO (JP) | 1998-06-10 | — | — | EP | disclosed |
| US-5726307-A | Benzo-fused lactams promote release of growth hormone | MERCK & CO., INC. (US) | 1998-03-10 | — | — | US | disclosed |
| EP-0821685-A1 | INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1998-02-04 | — | — | EP | disclosed |
| EP-0810214-A1 | PROCESS FOR PRODUCING INDOLINE COMPOUNDS AND INTERMEDIATES FOR THE PRODUCTION OF THE SAME | TOKYO TANABE COMPANY LIMITED (JP) | 1997-12-03 | — | — | EP | disclosed |
| EP-0810214-A1 | PROCESS FOR PRODUCING INDOLINE COMPOUNDS AND INTERMEDIATES FOR THE PRODUCTION OF THE SAME | TOKYO TANABE COMPANY LIMITED (JP) | 1997-12-03 | — | — | EP | disclosed |
| US-5643922-A | Indole cyclohexyl platelet activating factor antagonists | ABBOTT LABORATORIES (US) | 1997-07-01 | — | — | US | disclosed |
| US-5641800-A | ALLEVIATE EFFECT OF SEPTIC SHOCK, ADULT RESPIRATORY DISTRESS SYNDROME, PANCREATITIS, TRAUMA, BRONCHIAL ASTHMA, ALLERGIC RHINITIS, AND RHEUMATOID ARTHRITIS | ELI LILLY AND COMPANY (US) | 1997-06-24 | — | — | US | disclosed |
| US-5639780-A | NON-STEROIDAL ANTIINFLAMMATORY AGENTS | MERCK FROSST CANADA, INC. (CA) | 1997-06-17 | — | — | US | disclosed |
| EP-0772592-A1 | 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS | ELI LILLY AND COMPANY (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1996037467-A1 | N-BENZYLINDOL-3-YL BUTANOIC ACID DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1996-11-28 | — | — | WO | disclosed |
| WO-1996033196-A1 | INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1996-10-24 | — | — | WO | disclosed |
| US-5567711-A | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists | ABBOTT LABORATORIES (US) | 1996-10-22 | — | — | US | disclosed |
| WO-1996025396-A1 | PROCESS FOR PRODUCING INDOLINE COMPOUNDS AND INTERMEDIATES FOR THE PRODUCTION OF THE SAME | TOKYO TANABE COMPANY LIMITED (JP) | 1996-08-22 | — | — | WO | disclosed |
| US-5502065-A | TREATING HEADACHES | PFIZER INC. (US) | 1996-03-26 | — | — | US | disclosed |
| WO-1996003376-A1 | 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS | ELI LILLY AND COMPANY (US) | 1996-02-08 | — | — | WO | disclosed |
| US-5459152-A | 3-(pyridin-3-yl)-7-(indol-3-yl)carbonyl-1H,3H-pyrrolo(1,2-c) thiazole derivatives; asthma | ABBOTT LABORATORIES (US) | 1995-10-17 | — | — | US | disclosed |
| US-5393761-A | Treatment of nervous system disorders | H. LUNDBECK A/S (DK) | 1995-02-28 | — | — | US | disclosed |
| US-5393761-A | Treatment of nervous system disorders | H. LUNDBECK A/S (DK) | 1995-02-28 | — | — | US | disclosed |
| EP-0636129-A1 | INDOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS | Pfizer Limited (GB) | 1995-02-01 | — | — | EP | disclosed |
| US-5374721-A | Benzo-fused lactams promote release of growth hormone | MERCK & CO., INC. (US) | 1994-12-20 | — | — | US | disclosed |
| EP-0470039-B1 | Novel 3-arylindole and 3-arylindazole derivatives | LUNDBECK & CO AS H (DK) | 1994-12-07 | — | — | EP | disclosed |
| EP-0470039-B1 | Novel 3-arylindole and 3-arylindazole derivatives | LUNDBECK & CO AS H (DK) | 1994-12-07 | — | — | EP | disclosed |
| EP-0621781-A1 | USE OF 3-ARYLINDOLE AND 3-ARYLINDAZOLE DERIVATIVES FOR THE TREATMENT OF PSYCHOSES | H. LUNDBECK A/S (DK) | 1994-11-02 | — | — | EP | disclosed |
| EP-0595924-A4 | PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LAB (US) | 1994-08-24 | — | — | EP | disclosed |
| EP-0547178-A4 | NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE | WARNER LAMBERT CO (US) | 1994-07-06 | — | — | EP | disclosed |
| EP-0595924-A1 | PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1994-05-11 | — | — | EP | disclosed |
| WO-1993021178-A1 | INDOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS | PFIZER LIMITED (GB) | 1993-10-28 | — | — | WO | disclosed |
| WO-1993014758-A1 | USE OF 3-ARYLINDOLE AND 3-ARYLINDAZOLE DERIVATIVES FOR THE TREATMENT OF PSYCHOSES | H. LUNDBECK A/S (DK) | 1993-08-05 | — | — | WO | disclosed |
| WO-1993014758-A1 | USE OF 3-ARYLINDOLE AND 3-ARYLINDAZOLE DERIVATIVES FOR THE TREATMENT OF PSYCHOSES | H. LUNDBECK A/S (DK) | 1993-08-05 | — | — | WO | disclosed |
| EP-0547178-A1 | NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE | WARNER-LAMBERT COMPANY (US) | 1993-06-23 | — | — | EP | disclosed |
| WO-1993001813-A1 | PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1993-02-04 | — | — | WO | disclosed |
| EP-0470039-A2 | Novel 3-arylindole and 3-arylindazole derivatives | H. LUNDBECK A/S (DK) | 1992-02-05 | — | — | EP | disclosed |
| EP-0470039-A2 | Novel 3-arylindole and 3-arylindazole derivatives | H. LUNDBECK A/S (DK) | 1992-02-05 | — | — | EP | disclosed |
| EP-0238226-B1 | Substituted 1,3,4,9-tetrahydropyrano [3,4-b]indole-1-acetic acids | AMERICAN HOME PRODUCTS CORPORATION (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4971960-A | ANTIINFLAMMATORY AGENTS, ANALGESICS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1990-11-20 | — | — | US | disclosed |
| US-4826994-A | FROM ISATIN | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-05-02 | — | — | US | disclosed |
| US-4775690-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1988-10-04 | — | — | US | disclosed |
| JP-S63166877-A | FULGIDE BASED PHOTOCHROMIC COMPOUND | YAMAHA CORP | 1988-07-11 | — | — | JP | disclosed |
| US-4721725-A | Aryl-cycloalkyl[b]pyrrole derivatives | E. R. SQUIBB & SONS, INC. (US) | 1988-01-26 | — | — | US | disclosed |
| EP-0238226-A1 | Substituted 1,3,4,9-tetrahydropyrano [3,4-b]indole-1-acetic acids | AMERICAN HOME PRODUCTS CORPORATION (US) | 1987-09-23 | — | — | EP | disclosed |
| US-4670462-A | ANTIINFLAMMATORY AND ANALGESIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1987-06-02 | — | — | US | disclosed |
| EP-0022634-B1 | ACYLATED INDOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS AND DRUGS COMPRISING THEM | TEIJIN LIMITED (JP) | 1983-04-06 | — | — | EP | disclosed |
| EP-0022634-A1 | Acylated indole derivatives, processes for their preparation and pharmaceutical compositions and drugs comprising them | TEIJIN LIMITED (JP) | 1981-01-21 | — | — | EP | disclosed |
| EP-0022634-A1 | Acylated indole derivatives, processes for their preparation and pharmaceutical compositions and drugs comprising them | TEIJIN LIMITED (JP) | 1981-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (24 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | ALOX15, ALOX5, ALOX12 | SLC6A4 2661/4885HTR2A 506/4885HTR1A 275/4885 |
| US-20050119234-A1 | Cannabimimetic indole derivatives | CNR2, CNR1, HTR2C | SLC6A4 140/4885HTR2A 8/4885HTR1A 16/4885 |
| US-20060172019-A1 | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders | CNR2, CNR1, GPER1 | SLC6A4 3377/4885HTR2A 1698/4885HTR1A 1085/4885 |
| US-20050124620-A1 | Indole derivatives having an acidic moiety that inhibit or modulate activity of p38 map kinase mediating a disease state; e.g., 3-(2-(4-pyridyl)ethyl)-5-(3-trifluoromethoxybenzamido)indole; enzyme inhibitors; antiarthritic, -inflammatory, and -carcinogenic agents; respiratory disorders; AIDS; Alzheimer's | MAPK1, IDO1, INMT | SLC6A4 1190/4885HTR2A 1350/4885HTR1A 795/4885 |
| US-20090281052-A1 | Indole Antiviral Compositions And Methods | IDO1, IDO2, MAVS | SLC6A4 84/4885HTR2A 117/4885HTR1A 60/4885 |
| US-20120270827-A1 | Indole Antiviral Compositions And Methods | IDO1, IDO2, MAVS | SLC6A4 84/4885HTR2A 117/4885HTR1A 60/4885 |
| US-20070082872-A1 | Indole-containing compounds with anti-tubulin and vascular targeting activity | TUBB3, TUBB1, TUBB | SLC6A4 548/4885HTR2A 1788/4885HTR1A 1652/4885 |
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CNR2, CNR1, GPR68 | SLC6A4 993/4885HTR2A 22/4885HTR1A 17/4885 |
| US-10752585-B2 | Process for the preparation of Zafirlukast and analogs thereof | CHUK, HRH2, CTSH | SLC6A4 2592/4885HTR2A 2084/4885HTR1A 1382/4885 |
| US-20200223826-A1 | Glucose-6-Phosphate Dehydrogenase (G6PD)-Modulating Agents And Methods Of Treating G6PD Deficiency | G6PD, DPYD, G6PC1 | SLC6A4 3617/4885HTR2A 2419/4885HTR1A 3901/4885 |
| US-20080146517-A1 | Indole Antiviral Compositions And Methods | IDO1, IDO2, MAVS | SLC6A4 84/4885HTR2A 117/4885HTR1A 60/4885 |
| US-20050143329-A1 | Indole antiviral compositions and methods | IDO1, IDO2, MAVS | SLC6A4 84/4885HTR2A 117/4885HTR1A 60/4885 |
| US-10266526-B2 | Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer | SMYD3, SMYD2, SNRPD3 | SLC6A4 1580/4885HTR2A 2794/4885HTR1A 3385/4885 |
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | SLC6A4 2870/4885HTR2A 4846/4885HTR1A 4485/4885 |
| US-20170325457-A1 | FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS | NSF, GET3, SLC47A2 | SLC6A4 979/4885HTR2A 4277/4885HTR1A 4591/4885 |
| US-20170355695-A1 | SMYD Inhibitors | SMYD3, SMYD2, SMURF2 | SLC6A4 1612/4885HTR2A 2608/4885HTR1A 3743/4885 |
| US-20180312493-A1 | Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses Therefor | UGT1A8, CYP2C8, CXCL8 | SLC6A4 4420/4885HTR2A 4829/4885HTR1A 3999/4885 |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | SLC6A4 2870/4885HTR2A 4846/4885HTR1A 4485/4885 |
| US-20080090871-A1 | CANNABIMIMETIC INDOLE DERIVATIVES | CNR2, CNR1, GPR34 | SLC6A4 343/4885HTR2A 36/4885HTR1A 52/4885 |
| US-20200216390-A1 | PROCESS FOR THE PREPARATION OF ZAFIRLUKAST AND ANALOGS THEREOF | CHUK, CTSH, HRH2 | SLC6A4 2198/4885HTR2A 1941/4885HTR1A 1323/4885 |
| US-20090318446-A1 | 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy | ABL1, CDK2, JAK2 | SLC6A4 1407/4885HTR2A 730/4885HTR1A 897/4885 |
| US-20110065715-A1 | Nogo Receptor Binding Small Molecules to Promote Axonal Growth | NGFR, GAP43, BDNF | SLC6A4 2391/4885HTR2A 1280/4885HTR1A 878/4885 |
| US-20080275102-A1 | 3-ACYLINDOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | F12, ECI1, NQO2 | SLC6A4 640/4885HTR2A 316/4885HTR1A 88/4885 |
| US-20110178038-A1 | Indole Antiviral Compositions And Methods | IDO1, IDO2, MAVS | SLC6A4 84/4885HTR2A 117/4885HTR1A 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.